IBDEI1ZZ ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,31874,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31874,1,3,0)
;;=3^Antenatal Screening,Unspec
;;^UTILITY(U,$J,358.3,31874,1,4,0)
;;=4^Z36.9
;;^UTILITY(U,$J,358.3,31874,2)
;;=^5151856
;;^UTILITY(U,$J,358.3,31875,0)
;;=Z36.83^^126^1633^19
;;^UTILITY(U,$J,358.3,31875,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31875,1,3,0)
;;=3^Fetal Screening for Cogenital Cardia Abnormality
;;^UTILITY(U,$J,358.3,31875,1,4,0)
;;=4^Z36.83
;;^UTILITY(U,$J,358.3,31875,2)
;;=^5151848
;;^UTILITY(U,$J,358.3,31876,0)
;;=Z36.2^^126^1633^6
;;^UTILITY(U,$J,358.3,31876,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31876,1,3,0)
;;=3^Antenatal Screening for Follow-up,Other
;;^UTILITY(U,$J,358.3,31876,1,4,0)
;;=4^Z36.2
;;^UTILITY(U,$J,358.3,31876,2)
;;=^5151842
;;^UTILITY(U,$J,358.3,31877,0)
;;=Z36.89^^126^1633^15
;;^UTILITY(U,$J,358.3,31877,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31877,1,3,0)
;;=3^Antenatal Screening,Other Specified
;;^UTILITY(U,$J,358.3,31877,1,4,0)
;;=4^Z36.89
;;^UTILITY(U,$J,358.3,31877,2)
;;=^5151854
;;^UTILITY(U,$J,358.3,31878,0)
;;=N39.0^^126^1634^57
;;^UTILITY(U,$J,358.3,31878,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31878,1,3,0)
;;=3^Urinary tract infection, site not specified
;;^UTILITY(U,$J,358.3,31878,1,4,0)
;;=4^N39.0
;;^UTILITY(U,$J,358.3,31878,2)
;;=^124436
;;^UTILITY(U,$J,358.3,31879,0)
;;=R31.9^^126^1634^23
;;^UTILITY(U,$J,358.3,31879,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31879,1,3,0)
;;=3^Hematuria, unspecified
;;^UTILITY(U,$J,358.3,31879,1,4,0)
;;=4^R31.9
;;^UTILITY(U,$J,358.3,31879,2)
;;=^5019328
;;^UTILITY(U,$J,358.3,31880,0)
;;=R31.0^^126^1634^22
;;^UTILITY(U,$J,358.3,31880,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31880,1,3,0)
;;=3^Gross hematuria
;;^UTILITY(U,$J,358.3,31880,1,4,0)
;;=4^R31.0
;;^UTILITY(U,$J,358.3,31880,2)
;;=^5019325
;;^UTILITY(U,$J,358.3,31881,0)
;;=N39.3^^126^1634^45
;;^UTILITY(U,$J,358.3,31881,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31881,1,3,0)
;;=3^Stress incontinence (female) (male)
;;^UTILITY(U,$J,358.3,31881,1,4,0)
;;=4^N39.3
;;^UTILITY(U,$J,358.3,31881,2)
;;=^5015679
;;^UTILITY(U,$J,358.3,31882,0)
;;=N39.41^^126^1634^54
;;^UTILITY(U,$J,358.3,31882,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31882,1,3,0)
;;=3^Urge incontinence
;;^UTILITY(U,$J,358.3,31882,1,4,0)
;;=4^N39.41
;;^UTILITY(U,$J,358.3,31882,2)
;;=^5015680
;;^UTILITY(U,$J,358.3,31883,0)
;;=N39.46^^126^1634^28
;;^UTILITY(U,$J,358.3,31883,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31883,1,3,0)
;;=3^Mixed incontinence
;;^UTILITY(U,$J,358.3,31883,1,4,0)
;;=4^N39.46
;;^UTILITY(U,$J,358.3,31883,2)
;;=^5015685
;;^UTILITY(U,$J,358.3,31884,0)
;;=Z90.79^^126^1634^5
;;^UTILITY(U,$J,358.3,31884,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31884,1,3,0)
;;=3^Acquired Absence of Oth Genital Organ(s)
;;^UTILITY(U,$J,358.3,31884,1,4,0)
;;=4^Z90.79
;;^UTILITY(U,$J,358.3,31884,2)
;;=^5063596
;;^UTILITY(U,$J,358.3,31885,0)
;;=N91.2^^126^1634^6
;;^UTILITY(U,$J,358.3,31885,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31885,1,3,0)
;;=3^Amenorrhea,Unspec
;;^UTILITY(U,$J,358.3,31885,1,4,0)
;;=4^N91.2
;;^UTILITY(U,$J,358.3,31885,2)
;;=^5015904
;;^UTILITY(U,$J,358.3,31886,0)
;;=N30.10^^126^1634^14
;;^UTILITY(U,$J,358.3,31886,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31886,1,3,0)
;;=3^Cystitis,Interstitial w/o Hematuria
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1ZZ 3788 printed Sep 23, 2025@19:55:07 Page 2
IBDEI1ZZ ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,31874,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,31874,1,3,0)
+4 ;;=3^Antenatal Screening,Unspec
+5 ;;^UTILITY(U,$J,358.3,31874,1,4,0)
+6 ;;=4^Z36.9
+7 ;;^UTILITY(U,$J,358.3,31874,2)
+8 ;;=^5151856
+9 ;;^UTILITY(U,$J,358.3,31875,0)
+10 ;;=Z36.83^^126^1633^19
+11 ;;^UTILITY(U,$J,358.3,31875,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,31875,1,3,0)
+14 ;;=3^Fetal Screening for Cogenital Cardia Abnormality
+15 ;;^UTILITY(U,$J,358.3,31875,1,4,0)
+16 ;;=4^Z36.83
+17 ;;^UTILITY(U,$J,358.3,31875,2)
+18 ;;=^5151848
+19 ;;^UTILITY(U,$J,358.3,31876,0)
+20 ;;=Z36.2^^126^1633^6
+21 ;;^UTILITY(U,$J,358.3,31876,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,31876,1,3,0)
+24 ;;=3^Antenatal Screening for Follow-up,Other
+25 ;;^UTILITY(U,$J,358.3,31876,1,4,0)
+26 ;;=4^Z36.2
+27 ;;^UTILITY(U,$J,358.3,31876,2)
+28 ;;=^5151842
+29 ;;^UTILITY(U,$J,358.3,31877,0)
+30 ;;=Z36.89^^126^1633^15
+31 ;;^UTILITY(U,$J,358.3,31877,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,31877,1,3,0)
+34 ;;=3^Antenatal Screening,Other Specified
+35 ;;^UTILITY(U,$J,358.3,31877,1,4,0)
+36 ;;=4^Z36.89
+37 ;;^UTILITY(U,$J,358.3,31877,2)
+38 ;;=^5151854
+39 ;;^UTILITY(U,$J,358.3,31878,0)
+40 ;;=N39.0^^126^1634^57
+41 ;;^UTILITY(U,$J,358.3,31878,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,31878,1,3,0)
+44 ;;=3^Urinary tract infection, site not specified
+45 ;;^UTILITY(U,$J,358.3,31878,1,4,0)
+46 ;;=4^N39.0
+47 ;;^UTILITY(U,$J,358.3,31878,2)
+48 ;;=^124436
+49 ;;^UTILITY(U,$J,358.3,31879,0)
+50 ;;=R31.9^^126^1634^23
+51 ;;^UTILITY(U,$J,358.3,31879,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,31879,1,3,0)
+54 ;;=3^Hematuria, unspecified
+55 ;;^UTILITY(U,$J,358.3,31879,1,4,0)
+56 ;;=4^R31.9
+57 ;;^UTILITY(U,$J,358.3,31879,2)
+58 ;;=^5019328
+59 ;;^UTILITY(U,$J,358.3,31880,0)
+60 ;;=R31.0^^126^1634^22
+61 ;;^UTILITY(U,$J,358.3,31880,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,31880,1,3,0)
+64 ;;=3^Gross hematuria
+65 ;;^UTILITY(U,$J,358.3,31880,1,4,0)
+66 ;;=4^R31.0
+67 ;;^UTILITY(U,$J,358.3,31880,2)
+68 ;;=^5019325
+69 ;;^UTILITY(U,$J,358.3,31881,0)
+70 ;;=N39.3^^126^1634^45
+71 ;;^UTILITY(U,$J,358.3,31881,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,31881,1,3,0)
+74 ;;=3^Stress incontinence (female) (male)
+75 ;;^UTILITY(U,$J,358.3,31881,1,4,0)
+76 ;;=4^N39.3
+77 ;;^UTILITY(U,$J,358.3,31881,2)
+78 ;;=^5015679
+79 ;;^UTILITY(U,$J,358.3,31882,0)
+80 ;;=N39.41^^126^1634^54
+81 ;;^UTILITY(U,$J,358.3,31882,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,31882,1,3,0)
+84 ;;=3^Urge incontinence
+85 ;;^UTILITY(U,$J,358.3,31882,1,4,0)
+86 ;;=4^N39.41
+87 ;;^UTILITY(U,$J,358.3,31882,2)
+88 ;;=^5015680
+89 ;;^UTILITY(U,$J,358.3,31883,0)
+90 ;;=N39.46^^126^1634^28
+91 ;;^UTILITY(U,$J,358.3,31883,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,31883,1,3,0)
+94 ;;=3^Mixed incontinence
+95 ;;^UTILITY(U,$J,358.3,31883,1,4,0)
+96 ;;=4^N39.46
+97 ;;^UTILITY(U,$J,358.3,31883,2)
+98 ;;=^5015685
+99 ;;^UTILITY(U,$J,358.3,31884,0)
+100 ;;=Z90.79^^126^1634^5
+101 ;;^UTILITY(U,$J,358.3,31884,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,31884,1,3,0)
+104 ;;=3^Acquired Absence of Oth Genital Organ(s)
+105 ;;^UTILITY(U,$J,358.3,31884,1,4,0)
+106 ;;=4^Z90.79
+107 ;;^UTILITY(U,$J,358.3,31884,2)
+108 ;;=^5063596
+109 ;;^UTILITY(U,$J,358.3,31885,0)
+110 ;;=N91.2^^126^1634^6
+111 ;;^UTILITY(U,$J,358.3,31885,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,31885,1,3,0)
+114 ;;=3^Amenorrhea,Unspec
+115 ;;^UTILITY(U,$J,358.3,31885,1,4,0)
+116 ;;=4^N91.2
+117 ;;^UTILITY(U,$J,358.3,31885,2)
+118 ;;=^5015904
+119 ;;^UTILITY(U,$J,358.3,31886,0)
+120 ;;=N30.10^^126^1634^14
+121 ;;^UTILITY(U,$J,358.3,31886,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,31886,1,3,0)
+124 ;;=3^Cystitis,Interstitial w/o Hematuria
